1 East Sussex Healthcare NHS Trust, UK.
2 Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, UK.
Eur Heart J Acute Cardiovasc Care. 2018 Mar;7(2):176-193. doi: 10.1177/2048872618758931. Epub 2018 Feb 16.
Frailty is increasingly seen among patients with acute cardiovascular disease. A combination of an ageing population, improved disease survival, treatable long-term conditions as well as a greater recognition of the syndrome has accelerated the prevalence of frailty in the modern world. Yet, this has not been matched by an expansion of research. National and international bodies have identified acute cardiovascular disease in the frail as a priority area for care and an entity that requires careful clinical decisions, but there remains a paucity of guidance on treatment efficacy and safety, and how to manage this complex group. This position paper from the Acute Cardiovascular Care Association presents the latest evidence about frailty and the management of frail patients with acute cardiovascular disease, and suggests avenues for future research.
衰弱在急性心血管疾病患者中越来越常见。人口老龄化、改善的疾病存活率、可治疗的长期疾病以及对该综合征的更广泛认识加速了衰弱在现代世界的流行。然而，这并没有伴随着研究的扩展。国家和国际机构已经将虚弱的急性心血管疾病患者确定为护理的优先领域，并且是需要仔细临床决策的实体，但关于治疗效果和安全性以及如何管理这一复杂群体的指导仍然很少。急性心血管护理协会的这份立场文件介绍了关于衰弱和急性心血管疾病虚弱患者管理的最新证据，并为未来的研究提供了途径。
